Top Picks for the New Era in Healthcare
Now that healthcare reform has passed, StreetAuthority's experts share their
areas of opportunity for
This Small Biotech Firm's Shares Could Rocket in the Next 30 Days
This development-stage biotech company
expects good news on its liver cancer
treatment within the month. And FDA approval could come next year.
My Simple Rules Just Brought in +11.3% in 8 Weeks
Expert trader, Mike Turner, has a portfolio full of winners thanks to a
simple set of rules. He's showing his readers that removing emotion from
trading can bring consistent profits. His readers have already seen gains of
+12.8%, +23.3% and even as high as +32.7%.
Go here to learn about Mike's rules.
This Company Can't Stop Printing Profits
As office equipment sales rebound, this tech supplier should see a
Lock in This 10.2% Yield Before It's Too Late
This booming oil and gas company won't be yielding double-digits much
longer. Wall Street is starting to take notice of this stock and sending its
share prices higher. Right now we like this company for its
increasing dividends and high appreciation
Net a +230% Gain by Ignoring This Common Ratio
It's the most commonly cited financial statistic in the world. But don't be
fooled: Misunderstanding when to use it and when not to use it could cost
you huge profits.
The Ultimate Emerging Market Stock
This heavy equipment maker should benefit from a pair of
Have a great
-- Editorial Staff
receiving this newsletter because you visited us at TopStockAnalysts.com
and registered to receive our complimentary tri-weekly investing
newsletter -- TopStockAnalysts Digest. If you feel you have
received this issue in error, please follow the instructions below to
unsubscribe or contact us by visiting our web site.
If you are
interested in advertising in this newsletter, or on our web site, please
visit this link.
This message was
sent by an automated message delivery platform. Please do not reply to this
email address. Any messages sent to this address will be automatically
deleted. We sincerely hope that you benefit from your subscription to this
complimentary newsletter, and we're willing to do whatever it takes to keep
you as a satisfied customer. However, if at any time you wish to discontinue
your subscription, you can do so by simply
visiting this link and confirming your request, or by calling (301)
Please note that
TopStockAnalysts is not a registered investment firm or broker/dealer.
Readers are advised that the material contained herein should be used solely
for informational purposes. TopStockAnalysts does not purport to tell or
suggest which investment securities members or readers should buy or sell
for themselves. Site users should always conduct their own research and due
diligence and obtain professional advice before making any investment
decision. TopStockAnalysts will not be liable for any loss or damage caused
by a reader's reliance on information obtained in this newsletter or on our
web site. Our readers are solely responsible for their own investment
contained herein does not constitute a representation by the publisher or a
solicitation for the purchase or sale of securities. Our opinions and
analyses are based on sources believed to be reliable and are written in
good faith, but no representation or warranty, expressed or implied, is made
as to their accuracy or completeness. All information contained in this
report should be independently verified with the companies mentioned. The
editor and publisher are not responsible for errors or omissions. Any
opinions expressed are subject to change without notice. Owners, employees
and writers may hold positions in the securities discussed in this report or
on our web site. StreetAuthority's Headquarter is located at 839-K Quince
Orchard Blvd, Gaithersburg, MD 20878-1614.